Faculty of Allied Health Sciences > Pharmacy

A new drug for amyotrophic lateral sclerosis !

(1/1)

710001757:
The amyotrophic lateral sclerosis disease kills nerve cells that control voluntary muscles, so patients gradually weaken and become paralyzed. Most die within three to five years, usually from respiratory failure.

The drug, called Radicava or edaravone for amyotrophic lateral sclerosis, or Lou Gehrig’s disease, was approved on Friday by the Food and Drug Administration. Radicava is only the second drug ever approved to treat A.L.S. The first, riluzole, was approved by the F.D.A. more than 20 years ago.

More details: https://www.nytimes.com/2017/05/05/health/fda-approves-lou-gehrigs-disease-drug.html?rref=collection%2Fsectioncollection%2Fhealth&action=click&contentCollection=health&region=rank&module=package&version=highlights&contentPlacement=2&pgtype=sectionfront

Navigation

[0] Message Index